Mounting evidence shows that constitutively activated STAT3 contributes to tumour development and progression in most cancers, including breast, prostate, gastric, pancreas, colorectum, cervix, ovary, lung, melanoma and blood cancers.6, 7, 8, 9, 10. The gene discussed is STAT3; the disease is cancer.